These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 34904074)
1. Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF. Zhang X; Qiu B; Wang Q; Sivaprasad S; Wang Y; Zhao L; Xie R; Li L; Kang W Front Med (Lausanne); 2021; 8():779413. PubMed ID: 34904074 [No Abstract] [Full Text] [Related]
2. The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines. Chen X; Zhang X; Gong Z; Yang Y; Zhang X; Wang Q; Wang Y; Xie R Front Public Health; 2022; 10():1040319. PubMed ID: 36733289 [TBL] [Abstract][Full Text] [Related]
3. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834 [TBL] [Abstract][Full Text] [Related]
4. Circulating level of homocysteine contributes to diabetic retinopathy associated with dysregulated lipid profile and impaired kidney function in patients with type 2 diabetes mellitus. Chen X; Zhang X; Nie Y; Gong Z; Sivaprasad S; Fung AT; Wang Q; Qiu B; Xie R; Wang Y Eye (Lond); 2023 May; 37(7):1383-1389. PubMed ID: 35739242 [TBL] [Abstract][Full Text] [Related]
5. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy. Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439 [TBL] [Abstract][Full Text] [Related]
6. Effect of glycemic control and dyslipidemia on plasma vascular endothelial growth factor and pigment epithelium-derived factor in diabetic retinopathy patients in Northern Nigeria. Unung PJ; Bassey IE; Etukudo MH; Udoh AE; Alhassan MB; Akpan UO Int J Health Sci (Qassim); 2020; 14(6):4-12. PubMed ID: 33192226 [TBL] [Abstract][Full Text] [Related]
7. Association of Dyslipidemia with Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Hospital-Based Study. Ezhilvendhan K; Sathiyamoorthy A; Prakash BJ; Bhava BS; Shenoy A J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S1062-S1067. PubMed ID: 35017930 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723 [TBL] [Abstract][Full Text] [Related]
9. Comparison of serum lipid profile in Type-2 Diabetics with and without retinopathy in Pakistani population. Amin ZA; Islam QU; Mehboob MA Pak J Med Sci; 2016; 32(6):1349-1353. PubMed ID: 28083024 [TBL] [Abstract][Full Text] [Related]
10. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Wu TT; Gao Y; Zheng YY; Ma YT; Xie X Lipids Health Dis; 2018 Aug; 17(1):197. PubMed ID: 30134981 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy. Katagiri M; Shoji J; Inada N; Kato S; Kitano S; Uchigata Y Int Ophthalmol; 2018 Apr; 38(2):607-615. PubMed ID: 28299499 [TBL] [Abstract][Full Text] [Related]
12. Correlation Between Glycolipid Metabolism Levels and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus. Wang S; Pan X; Zhang M; Chen S Diabetes Metab Syndr Obes; 2024; 17():1-9. PubMed ID: 38192497 [TBL] [Abstract][Full Text] [Related]
13. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy. Bonfiglio V; Platania CBM; Lazzara F; Conti F; Pizzo C; Reibaldi M; Russo A; Fallico M; Ortisi E; Pignatelli F; Longo A; Avitabile T; Drago F; Bucolo C Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334029 [TBL] [Abstract][Full Text] [Related]
14. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy. Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of SOCS6 are decreased in diabetic retinopathy and are related to severity of the disease. Li L; Wu X; He L; Luo R; Lou L Adv Clin Exp Med; 2023 Aug; 32(8):873-880. PubMed ID: 37589228 [TBL] [Abstract][Full Text] [Related]
16. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients. Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840 [TBL] [Abstract][Full Text] [Related]
17. Exploring the Association of VEGF-A and ANGPTL2 with the Prognosis of Non-proliferative and Proliferative Diabetic Retinopathy. Shakthiya T; Chand L; Annamalai R; K A AS Cureus; 2024 Aug; 16(8):e68273. PubMed ID: 39350883 [TBL] [Abstract][Full Text] [Related]
18. The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape. Bage IJ; Kamalanathan S; Selvarajan S; Sahoo J; Jayanthi M; Naik D Cureus; 2023 Sep; 15(9):e45985. PubMed ID: 37900537 [TBL] [Abstract][Full Text] [Related]
19. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy. Koleva-Georgieva DN; Sivkova NP; Terzieva D Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106 [TBL] [Abstract][Full Text] [Related]
20. The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease. Li Y; Feng Y; Li S; Ma Y; Lin J; Wan J; Zhao M Front Cardiovasc Med; 2023; 10():1140215. PubMed ID: 37441702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]